Organovo expects FDA meeting in 2019 on 3D-bioprinted tissues for liver disease treatment
The biotech estimates that it has sufficient funds to meet operating and capital requirements through fiscal 2020
Sector
Health
1063 stories · page 53 of 54
Senseonics rallies after FDA approval of use of implantable glucose monitor during MRI
All other continuous glucose monitors must be removed before an MRI scan, according to the company
TransEnterix's digital laparoscopy device gets green light from FDA
The company's Senhance Ultrasonic system is approved for use in the US for laparoscopic colorectal, gynecological and gallbladder removal surgery
PolarityTE prepares for launch of SkinTE in 2019; posts $1.1M in revenue in fiscal 4Q
PolarityTE focuses on developing a range of regenerative tissue products and SkinTE is its flagship product for skin repair and reconstruction
Puration shares pop after saying it's pouring more resources in cannabis beverage business
Company wants to take advantage of the move by major beverage players into the cannabis sector
TransEnterix shares pop after FDA clears robotic surgery instruments
The FDA’s clearance of the 3 millimeter diameter instruments will allow the company’s Senhance robotic surgery system to be used for microlaparoscopic surgeries
Judges Scientific PLC - 2018 Interim Results
Judges Scientific reported results for the first half of 2018. The period included a first-time contribution from Oxford Cryosystems, which was acquired in July 2017. Organic growth of order intake and sales was solid and well in line with
Organovo reports smaller loss and sharp fall in revenue
The net loss for the quarter was lower compared to last year but revenues slid
TransEnterix posts bigger 2Q loss although revenue tops expectation
Shares of TransEnterix tumbled following a bigger-than-expected earnings miss
CRISPR stocks in focus after research shows edited cells might cause cancer
CRISPR Therapeutics shares recovered after it said ‘the theoretical risks’ described in the papers didn’t apply to its ‘high-efficiency gene correction’ program
Shares of Organovo fall after it narrows fiscal 2018 guidance
The San Diego company, which develops 3D human tissue models, also missed fiscal 3Q revenue estimates
TransEnterix shares pop after FDA approves its robotic surgery system for more procedures
Company says FDA clearance doubles total addressable market in US to more than three million annual procedures
Obalon Therapeutics shares plunge after bigger-than-expected 1Q loss on sliding revenue
The San Diego medical device maker missed Wall Street earnings estimates after revenue declined
TransEntrix soars after it posts smaller than expected 1Q loss on surging sales of its surgical robots
The North Carolina company is targeting higher sales of its Senhance System, a new robotically-assisted surgical device in the second quarter
Intellia Therapeutics gets Market Perform rating at Oppenheimer
Analyst Leah Rush Cann says there could be ‘significant upside’ if the biotech gets a ‘stronger patent foothold’ for CRISPR technology
PolarityTE looks to raise US$32mln for R&D in stock offering
More than 2 million shares will be offered at US$16 apiece
Optibiotix Health - Microbiome Specialist Entering Commercial Phase
OptiBiotix Health Plc (LON:OPTI) focuses on managing and treating widespread, chronic medical conditions, such as obesity and high cholesterol, through the modulation of the human microbiome.
Widecells - Fast-growing Provider of Stem Cell Services
WideCells Group PLC ( LON:WDC) was originally set-up in 2012 in Portugal, as a provider of stem cell storage services for the Portuguese and Spanish markets. In 2016 the company was listed on the London Stock Exchange, raising £1.7mln - net
Optibiotix Health - Rapidly Transitioning to Commercial Phase
Preventing and treating diseases through the modulation of the microbiome is one of the most exciting frontiers of healthcare, and a fast growing market OptiBiotix Health PLC (LON:OPTI), an innovative life sciences company focused on human
Judges Scientific - Capital Network: Interim Results
1H 2017 INTERIM RESULTS Judges Scientific Plc (LON:JDG) reported strong 1H 2017 results delivering record figures across revenues, adjusted profit before tax, adjusted earnings per share, and dividends. The management expects to meet the cu